Outcomes of patients receiving a massive transfusion for major trauma. BJS 2018; 105: 1426-1434.
Published: 12th July 2018
Authors: A. Endo, A. Shiraishi, K. Fushimi, K. Murata, Y. Otomo
The benefits of high transfusion ratios (plasma to red blood cells and platelets to red blood cells) on survival in injured patients who receive massive transfusions remain uncertain. This study aimed to assess the association between transfusion ratios and adverse events and survival in patients undergoing massive transfusion for major trauma.
A retrospective observational study was conducted on patients who had major trauma using a Japanese national administrative database. The associations between transfusion ratios and outcomes (in‐hospital mortality and incidence of adverse events) were analysed using a non‐linear logistic generalized additive model (GAM). In a logistic generalized estimating equation model, adjusted for patient and hospital‐level confounders, transfusion ratios were included as continuous or categorical variables (low, transfusion ratio 0·75 or less; intermediate, over 0·75 to 1·25; high, over 1·25).
Some 1777 patients were included in the analysis, of whom 602 died in hospital. GAM plots of the transfusion ratios for in‐hospital mortality demonstrated a downward convex unimodal curve. In‐hospital mortality was similar with increasing transfusion ratios for plasma (adjusted odds ratio (OR) 1·13, 95 per cent c.i. 0·82 to 1·55; P = 0·446) and platelets (adjusted OR 0·84, 0·66 to 1·08; P = 0·171). Both plasma to red blood cell ratio (adjusted OR 1·77, 1·32 to 2·37; P < 0·001) and platelet to red blood cell ratio (adjusted OR 1·71, 1·35 to 2·15; P < 0·001) were significantly associated with a higher incidence of adverse events. No significant differences in in‐hospital mortality were observed between the three transfusion categories (low, medium and high).
In this study, transfusion strategies with high plasma to red blood cell and platelet to red blood cell ratios did not have survival benefits, but were associated with an increase in adverse events.Full text
You may also be interested in
Authors: R. Miller, J. C. R. Wormald, R. G. Wade, D. P. Collins
Time to calcitonin normalization after surgery for node‐negative and node‐positive medullary thyroid cancer.
Authors: A. Machens, K. Lorenz, H. Dralle
Notes: Sensitive as prognostic tool
Contralateral surgery in patients scheduled for total thyroidectomy with initial loss or absence of signal during neural monitoring.
Authors: A. Sitges‐Serra, L. Gallego‐Otaegui, J. Fontané, L. Trillo, L. Lorente‐Poch, J. Sancho et al.
Authors: L. M. Almond, F. Tirotta, H. Tattersall, J. Hodson, T. Cascella, M. Barisella et al.
Notes: Weak for liposarcoma
Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death. BJS 2019; 106: 174-180.
Authors: I. M. Shapey, A. Summers, T. Augustine, D. van Dellen
Prioritizing research for patients requiring surgery in low‐ and middle‐income countries. BJS 2019; 106: e113-e120.
Authors: D. Nepogodiev, R. Moore, B. Biccard, S. Rayne, A. Costas‐Chavarri, M. C. Lapitan et al.
Notes: Priorities agreed
Caesarean section performed by medical doctors and associate clinicians in Sierra Leone. BJS 2019; 106: e129-e137.
Authors: A. J. van Duinen, M. M. Kamara, L. Hagander, T. Ashley, A. P. Koroma, A. Leather et al.
Authors: S. P. Stawicki, B. C. Nwomeh, G. L. Peck, Z. C. Sifri, M. Garg, J. V. Sakran et al.
Notes: Agreed framework with high standards needed
Authors: T. G. Weiser, J. A. Forrester, T. Negussie
Authors: L. Roa, D. T. Jumbam, E. Makasa, J. G. Meara
Notes: Must work to agreed national plans
Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy. BJS 2019; 106: e103-e112.
Authors: Hannah S Thomas, Thomas G Weiser, Thomas M Drake, Stephen R Knight, Cameron Fairfield, Adesoji O Ademuyiwa et al.